Published in Surgery Litigation and Law Weekly, November 26th, 2004
Results from the multi-center study were presented at the 2004 Annual Meeting of the American Society of Anesthesiologists.
"Zofran was well-tolerated and significantly more effective than placebo in preventing POV in young children in this study," said Samia N. Khalil, MD, professor, pediatric anesthesia, University of Texas Health Science Center, and lead investigator of the study.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly